Vaso Corporation (OTCQX: VASO) appoints finance leader Shaun McMeans to board
Rhea-AI Filing Summary
Vaso Corporation appointed Shaun McMeans, age 64, as a Class III director and member of the board’s audit committee, effective July 23, 2026. He is designated as a financial expert based on extensive finance and accounting leadership roles in life sciences and technology companies, including prior service as Chief Financial Officer of HTG Molecular Diagnostics, Inc. and his current role as CFO of Nabsys.
The company states there are no family relationships or related-party transactions involving McMeans and no arrangements with other parties leading to his appointment. As a non-employee director, he will receive pro-rated director compensation and a one-time new director grant of 100,000 shares of Vaso common stock.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.02, 9.01
2 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
New director equity grant: 100,000 shares of Vaso common stock
Director age: 64
Appointment effective date: July 23, 2026
+1 more
4 metrics
New director equity grant
100,000 shares of Vaso common stock
One-time new director grant to Shaun McMeans upon board appointment
Director age
64
Age of Shaun McMeans at time of appointment as Class III director
Appointment effective date
July 23, 2026
Effective date of Shaun McMeans’ appointment to the board and audit committee
Company phone
(516) 997-4600
Registrant’s telephone number listed for Vaso Corporation
Key Terms
Class III director, audit committee, financial expert, related party transaction, +1 more
5 terms
Class III director regulatory
"appointed by the Board of Directors as a Class III director of the Company"
A Class III director is a board member placed in one of the numbered groups used by companies with a staggered (or “classified”) board; that director’s seat typically comes up for election in the third year of a three-year rotation. For investors this matters because staggered terms create continuity but also make it harder to replace the whole board quickly, affecting shareholder influence, takeover dynamics and how fast new strategy or accountability can be implemented — like replacing only some players on a sports team each season instead of the whole roster at once.
audit committee regulatory
"Mr. McMeans will serve as a member of the Board’s audit committee"
A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.
financial expert financial
"will serve as a member of the Board’s audit committee and qualifies as a financial expert"
forward-looking statements regulatory
"This press release may contain forward-looking statements within the meaning of the federal securities laws"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What board change did Vaso Corporation (VASO) announce on July 23, 2026?
Vaso Corporation appointed Shaun McMeans as a Class III director and member of its audit committee, effective July 23, 2026. He joins the board as a non-employee director with extensive CFO experience in life sciences and technology companies.
What is Shaun McMeans’ background relevant to his new role at VASO?
Shaun McMeans is currently Chief Financial Officer of Nabsys and formerly CFO of HTG Molecular Diagnostics, Inc. He has held senior finance roles at multiple companies and holds a B.S. in Accounting from The Pennsylvania State University.
Will Vaso Corporation (VASO) grant equity to new director Shaun McMeans?
Yes. Upon joining the board, Shaun McMeans will receive a one-time new director grant of 100,000 shares of Vaso common stock, in addition to a pro-rated portion of the company’s standard non-employee director compensation.
What board responsibilities will Shaun McMeans have at Vaso Corporation (VASO)?
Shaun McMeans will serve as a Class III director and sit on Vaso’s audit committee. The company notes that he qualifies as a financial expert, reflecting his public company finance, accounting and operational experience.